M. Baldini et al., HUMAN LYMPHOCYTE ANTIGENS IN GRAVES-DISEASE - CORRELATION WITH PERSISTENT COURSE OF DISEASE, The American journal of the medical sciences, 309(1), 1995, pp. 43-48
Graves' disease is a thyroid autoimmune disorder associated with speci
fic human lymphocyte antigen (HLA) alleles, characterized by an unpred
ictable long-term course. To investigate possible relations between HL
A phenotype and outcome of the disease, the authors typed for HLA anti
gens in 105 patients with Graves' disease with different course of dis
ease. Al]. patients were treated with antithyroid drugs for at least 1
2 months; 29 patients had stable remission 24 or more months after wit
hdrawal of treatment; 76 patients had persistent disease-66 unremittin
g/relapsing hyperthyroidism, 10 stable hypothyroidism-36 or more month
s after onset of disease. The following findings emerged from this stu
dy: 1) HLA B8 and DR3 were increased significantly in Graves' patients
versus 6,682 control subjects from the same geographic area (23.80% v
s 12.01%, odds ratio [OR] 1.98, and 31.43% vs 18.00%, OR 1.75, respect
ively); the antigen combinations B8-DR3, B8-Cw7-DR3, and A1-B8-Cw7-DR3
were significantly more frequent in Graves' patients vs control subje
cts; in addition, these combinations were present exclusively in patie
nts with persistent disease (B8-DR3 28.95%, OR 7.14, B8-Cw7-DR3 27.63%
, OR 11.24, and A1-B8-Cw7-DR3 18.42%, OR 11.29). These data provide ev
idence that not only susceptibility to Graves' disease, but also persi
stent activity of the autoimmune process, producing either hyperthyroi
dism or stable hypothyroidism, is associated with specific HLA antigen
phenotypes.